Nuclear Regulatory Commission March 13, 2012 – Federal Register Recent Federal Regulation Documents

The Nuclear Regulatory Commission (NRC or the Commission) is considering the issuance of a license to General Electric-Hitachi Global Laser Enrichment LLC (GLE or the applicant) to authorize construction of a laser-based uranium enrichment facility and possession and use of byproduct material, source material, and special nuclear material (SNM). This proposed facility is proposed to be located in Wilmington, North Carolina. The NRC prepared a Safety Evaluation Report (SER) in support of this license application.

NRC will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 16-17, 2012. A sample of agenda items to be discussed during the public session includes: (1) Fundamental concepts in patient advocacy; (2) electronic signatures for documents that are required to be signed in accordance with U.S. Nuclear Regulatory Commission (NRC) regulations; (3) medical-related events from fiscal year 2011; (4) an update on proposed regulatory changes for Permanent Implant Brachytherapy programs; (5) the status of the Commission Paper on data collection for Patient Release; (6) a status update on 10 CFR Part 35 rulemaking; (7) medical use of radium- 223 chloride; (8) an update on strontium breakthrough with rubidium-82 generators from NRC and FDA perspectives; and (9) half-life activity as a function of solar activity. The agenda is subject to change. The current agenda and any updates will be available at https://www.nrc.gov/ reading-rm/doc-collections/acmui/agenda or by emailing Ms. Sophie Holiday at the contact information below. Purpose: Discuss issues related to 10 CFR Part 35 Medical Use of Byproduct Material. Date and Time for Closed Session: April 16, 2012, from 8 a.m. to 10:45 a.m. This session will be closed so that ACMUI members can prepare for an upcoming Commission briefing. Date and Time for Open Sessions: April 16, 2012, from 10:45 a.m. to 5 p.m. and April 17, 2012, from 8 a.m. to 12:30 p.m. Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two White Flint North Building, Room T2- B3, 11545 Rockville Pike, Rockville, Maryland 20852. Public Participation: Any member of the public who wishes to participate in the meeting in person or via phone should contact Ms. Holiday using the information below. The meeting will also be webcast live: https://www.nrc.gov/public-involve/public-meetings/webcast- live.html. Contact Information: Sophie J. Holiday, email: sophie.holiday@nrc.gov, telephone: (301) 415-7865.